Hgsoc - OmicsDI

Show results for

Unknown (884)
Genomics (351)
Transcriptomics (173)
Proteomics (67)
Other (23)
Methylation profiling (14)
Clinical (2)
Metabolomics (1)

Organisms

Homo sapiens (267)
Aerococcus urinae NBRC 15544 = CCUG 36881 (59)
Alteromonadales (59)
Bacteria (59)
Canis lupus familiaris (59)
Carya cathayensis (59)
Ectopseudomonas oleovorans CECT 5344 (59)
Ensifer adhaerens (59)
Enterococcus faecalis (59)
Globicatella sanguinis (59)
Halictus scabiosae (59)
Histomonas meleagridis (59)
Human immunodeficiency virus 1 (59)
Mesocricetus auratus (59)
Methylohalobius crimeensis 10Ki (59)
Mus musculus (59)
Olavius algarvensis sulfate-reducing endosymbiont (59)
Ophrys garganica (59)
Ophrys sphegodes (59)
Pseudomonas aeruginosa SJTD-1 (59)
Pseudomonas putida KT2440 (59)
Rabies virus Nishigahara RCEH (59)
Rattus norvegicus (59)
Rattus rattus (59)
Rhodococcus jostii RHA1 (59)
Rhodopseudomonas palustris (59)
Schizosaccharomyces pombe 927 (59)
Staphylococcus aureus (59)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (59)
Mus musculus (24)

Organisms

Homo sapiens (223)
Mus musculus (20)

Repository

ENA (279)
geo (207)
pride (59)
EGA (48)
biostudies-arrayexpress (27)
iProX (4)
MassIVE (2)
PanoramaPublic (2)
MetaboLights (1)

Tissue

Epithelial cell (21)
Cell culture (19)
Ovarian serous carcinoma cell (8)
Epithelial ovarian cancer cell (6)
Ovarian surface epithelial cell (5)
Blood serum (3)
Ascites (2)
Blood plasma (2)
Cell suspension culture (2)
Malignant cell (2)
Ovarian epithelial cell (2)
Ovary (2)
Ovary epithelium (2)
Oviduct epithelium (2)
Stromal cell (2)
T cell (2)
Endocervical epithelium (1)
Fibroblast (1)
Internal female genital organ (1)
Macrophage (1)
Melanocyte (1)
Ovarian cortex (1)
Ovary cancer cell (1)
Ovary stroma (1)
Oviduct (1)
Permanent cell line cell (1)
Primary cell (1)
Stem cell (1)
Tissues (1)
Whole body (1)

Disease

Malignant neoplasm of ovary (38)
Ovarian serous carcinoma (7)
Ovary epithelial cancer (2)
Ovary serous adenocarcinoma (2)
Carcinoma (1)
Neoplasms (1)
Acute leukemia (1)
Colon cancer (1)
Ovarian cancer (1)

Technology Type

Mass Spectrometry (59)
Shotgun proteomics (26)
Bottom-up proteomics (21)
Data-independent acquisition (8)
Data-dependent acquisition (7)
Top-down proteomics (5)
SWATH MS (4)
Affinity purification coupled with mass spectrometry proteomics (2)
DiaPASEF (2)
Gel-based experiment (2)
Illumina HiSeq 2500, ILLUMINA, Illumina MiSeq, HiSeq X Ten (1)
Illumina HiSeq2000 (1)
Complete Genomics (COMPLETE_GENOMICS) (1)
Illumina HiSeq 2500, ILLUMINA (1)
Illumina MiSeq, Illumina HiSeq 2500 (1)
Illumina HiSeq 2000, ILLUMINA, Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
Mass spectrometry assay (1)
SRM/MRM (1)

Instrument Platform

Illumina HiSeq 2000 (2)
NextSeq 500 (2)
Q Exactive (2)
QIAcube (Qiagen) (1)
EpMotion 5075 automated pipetting system (Eppendorf, Hamburg, Germany) (1)
Illumina Genome Analyzer IIx (1)
Illumina NovaSeq 6000 (1)
Autoflex II (1)
TimsTOF fleX (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2025 (53)
2026 (38)
2024 (38)
2020 (32)
2021 (29)
2022 (28)
2023 (21)
2019 (17)
2016 (14)
2017 (9)
2015 (8)
2018 (5)
2014 (5)
2011 (1)

Metabolite Name

Sphingosine-1-phosphate (1)
C17 Sphinganine-1-phosphate (1)
C17 Sphinganine (1)
Sphingosine (1)

First Public Date

2025 (50)
2024 (46)
2026 (40)
2022 (35)
2020 (34)
2021 (23)
2023 (18)
2019 (16)
2016 (5)
2018 (4)
2015 (4)
2017 (2)
2014 (2)

Study status

Active, not recruiting (1)
Recruiting (1)

Study type

Transcription profiling by array (10)
RNA-seq of coding RNA (9)
Methylation profiling by array (3)
Cell line - High-throughput sequencing (1)
Genotyping by array (1)
Comparative genomic hybridization by array (1)
ChIP-seq (1)
MicroRNA profiling by array (1)
Observational (1)
Interventional (1)

Release Date

2023 (116)
2025 (115)
2022 (115)
2021 (111)
2024 (106)
2020 (98)
2019 (72)
2018 (49)
2016 (42)
2017 (30)
2015 (24)
2026 (18)
2014 (9)
2013 (3)
2011 (1)
2012 (1)

Lab affiliation

Cancer Biology Department, Fox Chase Cancer Center, Philadelphia, PA, USA (3)
Cedars-Sinai Medical Center (3)
Director of Women’s Health Research Women’s Service Line Inova Health System (3)
Proteomics core facility, Biomedical Research Institute, Seoul National University Hospital (2)
BRIC-National Centre for Cell Science, Inside Pune Univesrity, Ganeshkhind, Pune, India, 411007 (1)
Bertis R&D Division, Bertis Inc., Republic of Korea (1)
Brown University (1)
CRUK - Beatson Institute for Cancer Research - Switchback Rd, Bearsden, Glasgow G61 1BD - United Kingdom (1)
Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver V5Z 1L3, Canada. (1)
Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA, USA (1)
Centre for Genomics and Computational Biology Barts Cancer Institute Queen Mary University of London John Vane Science Centre, Charterhouse Square, London EC1M 6BQ (1)
Clinical Research Division, Fred Hutchinson Cancer Research Center (1)
Department of Chemistry, University of Illinois Chicago, Chicago, USA (1)
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas (1)
Department of Laboratory Medicine & Pathology, University of Minnesota (1)
Department of Laboratory Medicine and Pathology University of Minnesota School of Medicine (1)
Department of Laboratory Medicine and Pathology, University of Minnesota School of Medicine, Minneapolis, Minnesota 55455, USA (1)
Department of Laboratory Medicine and Patholoogy, University of Minnesota. Minneapolis, MN, USA (1)
Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. (1)
Department of Microbiology, Molecular Genetics and Immunology, University of Kansas Medical Center, Kansas City, Kansas, USA (1)
Department of Pharmaceutical Sciences University of Maryland Baltimore, Maryland USA (1)
Director of Women’s Health Research Women’s Service Line Inova Health System Chief Scientific Officer Gynecologic Cancer Center of Excellence John P. Murtha Cancer Center Research Program Uniformed Services University of the Health Sciences (1)
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Cancer Research Centre, Wilmslow Road, Manchester M20 4GJ, United Kingdom (1)
Functional Proteomics, ICR (1)
Genomic Stability Lab (GSL), Manchester Cancer Research Centre, Division of Cancer Sciences, Faculty of Biology Medicine and Health, University of Manchester, UK (1)
Head of Proteomics & Metabolomics Facility (1)
Head of the Curie Institute Mass Spectrometry Platform (1)
Immunology, Moffitt Cancer Center, Tampa, FL (1)
Inova Health System (1)
Institute for Glyco-core Research (iGCORE), Nagoya University, Aichi, Japan (1)

Location

Canada (2)
Italy (1)
Spain (1)
United States (1)
United Kingdom (1)
France (1)

Keyword

HER2-Negative Breast Cancer (1)
High-Grade Serous Ovarian Cancer (1)
HGSOC (1)
GEJ Carcinoma (1)
Personalized patient-derived xenografts (pPDX) (1)
Drug sensitivity testing (1)
Serous (1)
Triple negative (1)
Seattle Genetics (1)
Metastatic (1)
Molecular profiling (1)
Epigenetic analysis (1)

Previous page
1 / 152
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 152
Next page

Sort by:

Relevance

Page size

RNA-seq of FFPE-macrodissected HGSOC tissues and solid and ascites-derived HGSOC 2D cultures

PRJEB40519 | ENA

Chemotherapy-induced extracellular matrix remodelling in HGSOC

PRJNA1128680 | ENA

RNA-seq of FFPE-macrodissected HGSOC tissues and solid and ascites-derived HGSOC 2D cultures

Stratification of a retrospective cohort of HGSOC based on its tissues of origin.

ORGANISM(S): Homo sapiens

2020-09-29 | E-MTAB-9605 | biostudies-arrayexpress

Gene expression in High-Grade Serous Ovarian Cancer (HGSOC) cells

PRJNA887714 | ENA

Single-cell B receptor VDJ sequencing from HGSOC isolated B cells

PRJNA661287 | ENA

Tri-cultures of HGSOC cells replicate tissue remodelling observed in biopsies.

PRJNA515261 | ENA

Orbitrap proteomic analysis of five distinct molecular subtypes of High Grade Serous Ovarian Carcinoma (HGSOC) under serum deprived and serum fed conditions

Cell lines representing five distinct phenotypes of high-grade serous ovarian carcinoma (HGSOC), including Epithelial (E), Intermediate-Epithelial (iE), Epithelial-Mesenchymal Hybrid (E/M), Intermediate-Mesenchymal (iM), and Mesenchymal (M), previously classified in our laboratory based on the expre...

ORGANISM(S): Homo sapiens (Human)

2025-10-08 | PXD062888 | Pride

RNA sequencing of 6 HGSOC and 5 FTE

PRJNA787960 | ENA

HGSOC organoid sequencing study

High-grade serous ovarian carcinoma (HGSOC) is the most genomically complex cancer, characterized by ubiquitous TP53 mutation, profound chromosomal instability and heterogeneity. The mutational processes driving chromosomal instability in HGSOC can be distinguished by specific copy number signatures...

EGAS00001007189 | EGA

Single-cell RNA sequencing samples from high-grade serous ovarian cancer (HGSOC)

PRJNA667060 | ENA

Previous page
1 / 152
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 152
Next page

Sort by:

Relevance

Page size

1515 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

First Public Date

Study status

Study type

Release Date

Lab affiliation

Location

Tags

Keyword

OmicsDI is part of the ELIXIR infrastructure

Tweets